IMMUNOBIOME Inc. – Trademark Portfolio
Entity Type: 03
IMMUNOBIOME Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AVATIOME and IMMUNOBIOME. The owner is based in Gyeongbuk.
(Jigok-dong, biotechcenter)
Gyeongbuk 37673 , KR
Showing of trademarks Trademarks
Trademark Classifications
IMMUNOBIOME Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does IMMUNOBIOME Inc. have?
IMMUNOBIOME Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does IMMUNOBIOME Inc. file in?
IMMUNOBIOME Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are IMMUNOBIOME Inc.'s most well-known trademarks?
IMMUNOBIOME Inc.'s registered trademark portfolio includes well-known marks such as AVATIOME and IMMUNOBIOME. These are among 2 currently registered trademarks in the portfolio.
What is IMMUNOBIOME Inc.'s trademark registration success rate?
IMMUNOBIOME Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.